Viramed® Biotech AG

Viramed® Biotech AG

 Based on more than 38 years of experience in European and American markets Viramed® develops, produces and sells In-Vitro-Diagnostic test kits. Through proprietary research and development the ViraChip® microarray product line is continuously expanding. 

 Viramed® focuses on the serological detection of autoantibodies as well as antibodies against infectious disease parameters like Borrelia, Yersinia, Treponema, Helicobacter, Bordetella, SARS-CoV-2, EBV, CMV, Hepatitis E Virus, Parvovirus B19, Zika Virus, Dengue Virus, Chikungunya Virus and Toxoplasma. 

 Software solutions, device design and manufacturing provide full automation for the ViraChip® technology in the diagnostic laboratory.

.